Compound
GrantsAbout

2026 Compound

Compound
GrantsAbout
Back to Database
Interfaces for neuromodulation
Healthcare

Interfaces for neuromodulation

Closing the loop from measurement → action

Concept

What if we didn’t have to meditate, run, or therapy to change our mental state?

Longer Description

A core premise for how we think a lot about neurotech is that there will be more than one sensor and modulator that will penetrate different use-cases in day-to-day life. A lot of strides have been made so far on the recording side in terms of miniaturization and signal-to-noise improvements broadening the environments its can be used in.

We’re starting to see papers on brain modulation which are a correspondingly miniaturizing brain modulation devices such as focused ultrasound (FUS) and transcranial magnetic stimulation (TMS). Specifically this paper introduces a new wearable device called MiniUlTra, designed for long-term brain stimulation using ultrasound. This small device combines an ultrasound transducer with a special sticky hydrogel that keeps it attached to the skin and working well for over a month. MiniUlTra can safely deliver strong ultrasound waves to modulate brain activity, showing it can effectively reduce certain neural responses (in this case in an area of the brain responsible for sensory perception). Shrunken TMS coils have also shown the ability to still modulate brain potentials such as single-unit activities (SUAs), somatosensory evoked potentials (SSEPs), and motor evoked potentials (MEPs) in rats.

Thesis image

Likely a venture-scale company will have a variety of principles including:

  • R&D Excellence: continuous pressure on miniaturization and higher precision and efficacy are incredibly important to keep an edge. Also modulation would likely need to be paired with highly sophisticated monitoring devices. Also continuous understanding of other brain monitoring tech such as transcranial magnetic stimulation is necessary.
  • Regulatory Foresight: Engagement with regulatory bodies will be an important strategy for company longevity, even if use-cases addressed don’t need to go through clinical trials.
  • Product selection and timing: Clear mapping of which technological milestones unlock which use-cases needs to be thoroughly planned with relative value unlock.

Comparable Companies

  • Attune Neuro
  • Neurosona
  • Insightec
  • NaviFUS

Related Reading

  • Combination of FUS with biologics
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608284/
  • https://www.nature.com/articles/s41386-023-01599-z
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037933/

Related Theses

Marketplaces Requiring Private Intelligence
01
AI/ML

Marketplaces Requiring Private Intelligence

For deals requiring human-like analysis and negotiation but can’t risk information leakage

Read
Personalized organoid aging
02
Healthcare

Personalized organoid aging

Longevity Intervention Testing

Read
Going direct with diagnostics
03
Healthcare

Going direct with diagnostics

Rise of consumer Tempus models

Read

2026 Compound